R. Barakat

R. Barakat, S. Olson, S. Harlap, 1997, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

Cost effectiveness and other assessments of adjuvant therapies for early breast cancer.

R. Barakat, 1995 .

The benefit of video-assisted thoracoscopic surgery before planned abdominal exploration in patients with suspected advanced ovarian cancer and moderate to large pleural effusions.

R. Barakat, D. Chi, R. Flores, 2004, Gynecologic oncology.

Improved optimal cytoreduction rates for stages IIIC and IV epithelial ovarian, fallopian tube, and primary peritoneal cancer: a change in surgical approach.

D. Levine, R. Barakat, W. Jarnagin, 2004, Gynecologic oncology.

Breast cancer metastatic to abdomen and pelvis: role of surgical resection.

E. Venkatraman, R. Barakat, M. Gemignani, 2003, Gynecologic oncology.

What influence does hormone replacement therapy have on endometrial cancer risk?

R. Barakat, 2005, Nature Clinical Practice Oncology.

A prospective study of the accuracy of 18Fluorodeoxyglucose positron emission tomography (18FDG PET) in identifying sites of metastasis prior to pelvic exenteration.

S. Larson, R. Barakat, D. Chi, 2007, Gynecologic oncology.

Gene therapy for endometrial carcinoma with the herpes simplex thymidine kinase gene.

R. Barakat, E. Ercikan-Abali, D. Banerjee, 2000, Gynecologic oncology.

Metastatic breast carcinoma to the abdomen and pelvis.

R. Barakat, C. Aghajanian, N. Abu-Rustum, 1997, Gynecologic oncology.

What is the optimal goal of primary cytoreductive surgery for bulky stage IIIC epithelial ovarian carcinoma (EOC)?

D. Levine, R. Barakat, D. Chi, 2007, Gynecologic oncology.

What do we expect from imaging?

H. Hricak, R. Barakat, 2002, Radiologic clinics of North America.

Peritoneal inclusion cysts: clinical characteristics and imaging features

H. Hricak, O. Akin, R. Barakat, 2013, European Radiology.

Sentinel lymph node mapping with pathologic ultrastaging: a valuable tool for assessing nodal metastasis in low-grade endometrial cancer with superficial myoinvasion.

R. Barakat, M. Leitao, R. Soslow, 2013, Gynecologic oncology.

Location of Disease in Patients Who Die From Endometrial Cancer: A Study of 414 Patients From a Single Institution

R. Barakat, D. Chi, M. Hensley, 2012, International Journal of Gynecologic Cancer.

Laparoscopy compared with laparotomy for comprehensive surgical staging of uterine cancer: Gynecologic Oncology Group Study LAP2.

R. Barakat, R. Mannel, Joan L. Walker, 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Accuracy of preoperative endometrial sampling diagnosis of FIGO grade 1 endometrial adenocarcinoma.

R. Barakat, D. Chi, M. Leitao, 2008, Gynecologic oncology.

Laparoscopically assisted surgical staging for endometrial cancer

R. Barakat, 2005 .

Endometrial cancer metastatic to infrarenal aortic lymph nodes unrecognized during laparoscopic inframesenteric aortic lymph node dissection.

R. Barakat, Joan L. Walker, N. Abu-Rustum, 2004, Gynecologic oncology.

Surgical management of advanced or recurrent endometrial cancer.

R. Barakat, D. Chi, 2001, The Surgical clinics of North America.

Prognostic Features of Surgical Stage I Uterine Carcinosarcoma

R. Barakat, A. Hummer, R. Soslow, 2007, The American journal of surgical pathology.

Sonohysterography Compared With Endometrial Biopsy for Evaluation of the Endometrium in Tamoxifen‐Treated Women

M. Gonen, R. Barakat, L. Hann, 2003 .

Prognostic Significance of the Number of Postoperative Intraperitoneal Chemotherapy Cycles for Patients With Advanced Epithelial Ovarian Cancer

R. Barakat, D. Chi, A. Iasonos, 2014, International Journal of Gynecologic Cancer.

The effect of primary cytoreduction on outcomes of patients with FIGO stage IIIC ovarian cancer stratified by the initial tumor burden in the upper abdomen cephalad to the greater omentum.

C. Sima, R. Barakat, D. Chi, 2010, Gynecologic oncology.

Detection of sentinel lymph nodes in minimally invasive surgery using indocyanine green and near-infrared fluorescence imaging for uterine and cervical malignancies.

Douglas A Levine, Carol L. Brown, D. Levine, 2014, Gynecologic oncology.

Establishing a sentinel lymph node mapping algorithm for the treatment of early cervical cancer.

R. Barakat, D. Chi, Kay J. Park, 2011, Gynecologic oncology.

Sentinel lymph node mapping for endometrial cancer improves the detection of metastatic disease to regional lymph nodes.

D. Levine, R. Barakat, D. Chi, 2011, Gynecologic oncology.

Improving sentinel lymph node detection rates in endometrial cancer: how many cases are needed?

D. Levine, R. Barakat, D. Chi, 2009, Gynecologic oncology.

The incidence of isolated paraaortic nodal metastasis in surgically staged endometrial cancer patients with negative pelvic lymph nodes.

R. Barakat, D. Chi, G. Gardner, 2009, Gynecologic oncology.

Sentinel lymph node mapping for grade 1 endometrial cancer: is it the answer to the surgical staging dilemma?

Carol L. Brown, D. Levine, R. Barakat, 2009, Gynecologic oncology.

Sentinel lymph node biopsy in the management of early-stage cervical carcinoma.

R. Barakat, D. Chi, M. Murray, 2011, Gynecologic oncology.

Diethyldithiocarbamate chemoprotection of carboplatin-induced hematological toxicity

R. Barakat, P. Francis, S. Rubin, 2005, Journal of Cancer Research and Clinical Oncology.

Association between pretreatment CA-125 levels and surgically documented complete responses in patients with ovarian cancer treated with second-line intraperitoneal therapy

R. Barakat, S. Rubin, M. Markman, 2005, Journal of Cancer Research and Clinical Oncology.

Quality of life in women at risk for ovarian cancer who have undergone risk-reducing oophorectomy.

Carol L. Brown, K. Offit, R. Barakat, 2003, Gynecologic oncology.

Improved survival for BRCA2‐associated serous ovarian cancer compared with both BRCA‐negative and BRCA1‐associated serous ovarian cancer

Alexia Iasonos, Kenneth Offit, Qin Zhou, 2012, Cancer.

Is Robotic-Assisted Surgery Safe in the Elderly Population? An Analysis of Gynecologic Procedures in Patients ≥ 65 Years Old

Carol L. Brown, R. Barakat, G. Gardner, 2018, Annals of Surgical Oncology.

Epithelial ovarian cancer in the elderly: The memorial sloan‐kettering cancer center experience

R. Barakat, P. Saigo, S. Rubin, 2010 .

The impact of bulky upper abdominal disease cephalad to the greater omentum on surgical outcome for stage IIIC epithelial ovarian, fallopian tube, and primary peritoneal cancer.

R. Barakat, D. Chi, A. Iasonos, 2008, Gynecologic oncology.

Paclitaxel and carboplatin in the adjuvant treatment of patients with high-risk stage III and IV endometrial cancer: a retrospective study.

R. Barakat, D. Chi, P. Sabbatini, 2006, Gynecologic oncology.

Paclitaxel-based chemotherapy in carcinoma of the fallopian tube.

R. Barakat, P. Saigo, E. Venkatraman, 2001, Gynecologic oncology.

Memorial Sloan-Kettering Cancer Center Experience with Intraperitoneal Chemotherapy of Ovarian Cancer

R. Barakat, D. Spriggs, 2000 .

Phase II trial of intraperitoneal cisplatin and mitoxantrone in patients with persistent ovarian cancer.

E. Venkatraman, R. Barakat, P. Sabbatini, 1999, Gynecologic oncology.

Intraperitoneal chemotherapy strategies in the treatment of epithelial ovarian carcinoma.

R. Barakat, P. Sabbatini, S. Makhija, 1999, Current opinion in obstetrics & gynecology.

A cross-sectional study of the psychosexual impact of cancer-related infertility in women: third-party reproductive assistance

R. Barakat, C. Sklar, R. Baser, 2010, Journal of cancer survivorship : research and practice.

Phase II trial of docetaxel in patients with platinum-refractory advanced ovarian cancer.

R. Barakat, P. Francis, C. Balmaceda, 1994, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Follow-up of Memorial Sloan-Kettering Cancer Center patients treated on National Cancer Institute Treatment Referral Center protocol 9103: paclitaxel in refractory ovarian cancer.

R. Barakat, M. Markman, J. Curtin, 1996, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Absence of premalignant histologic, molecular, or cell biologic alterations in prophylactic oophorectomy specimens from BRCA1 heterozygotes

K. Offit, J. Boyd, R. Barakat, 2000, Cancer.

Hepatic resection for metastatic gynecologic carcinomas.

R. Barakat, D. Chi, Y. Fong, 1997, Gynecologic oncology.

Morbidity of rectosigmoid resection and primary anastomosis in patients undergoing primary cytoreductive surgery for advanced epithelial ovarian cancer.

R. Barakat, B. Bochner, D. Chi, 2005, Gynecologic oncology.

Laparoscopic bilateral salpingo-oophorectomy in breast cancer patients after transverse rectus abdominus myocutaneous flap reconstructive surgery.

J. Disa, R. Barakat, A. Hummer, 2005, Gynecologic oncology.

Transperitoneal laparoscopic pelvic and para-aortic lymph node dissection using the argon-beam coagulator and monopolar instruments: an 8-year study and description of technique.

Carol L. Brown, R. Barakat, D. Chi, 2003, Gynecologic oncology.

The rate of port-site metastases after 2251 laparoscopic procedures in women with underlying malignant disease.

Carol L. Brown, D. Levine, R. Barakat, 2008, Gynecologic oncology.

Subcutaneous Tumor Implantation After Laparoscopic Procedures in Women With Malignant Disease

R. Barakat, D. Chi, M. Gemignani, 2004, Obstetrics and gynecology.

Transfusion utilization during adnexal or peritoneal cancer surgery: effects on symptomatic venous thromboembolism and survival.

R. Barakat, D. Chi, M. Gemignani, 2005, Gynecologic oncology.

Extended pelvic resections for recurrent uterine and cervical cancer: out-of-the-box surgery

R. Barakat, B. Bochner, D. Chi, 2007, International Journal of Gynecologic Cancer.

Resection of recurrent cervical cancer after total pelvic exenteration

R. Barakat, B. Bochner, D. Chi, 2006, International Journal of Gynecologic Cancer.

What is the incidence of isolated paraaortic nodal recurrence in grade 1 endometrial carcinoma?

R. Barakat, D. Chi, M. Leitao, 2008, Gynecologic oncology.

The incidence of symptomatic lower-extremity lymphedema following treatment of uterine corpus malignancies: a 12-year experience at Memorial Sloan-Kettering Cancer Center.

R. Barakat, D. Chi, A. Iasonos, 2006, Gynecologic oncology.

Screening for endometrial cancer in the patient receiving tamoxifen for breast cancer.

R. Barakat, 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Pelvic exenteration with curative intent for recurrent uterine malignancies.

Carol L. Brown, R. Barakat, B. Bochner, 2012, Gynecologic oncology.

Anterior pelvic exenteration with total vaginectomy for recurrent or persistent genitourinary malignancies: review of surgical technique, complications, and outcome.

R. Barakat, B. Bochner, D. Chi, 2012, Gynecologic oncology.

Diagnostic x-rays and risk of epithelial ovarian carcinoma in Jews.

R. Barakat, S. Olson, T. Caputo, 2002, Annals of epidemiology.

Stage IV ovarian cancer: impact of surgical debulking.

E. Venkatraman, R. Barakat, J. Curtin, 1997, Gynecologic oncology.

The significance of cytological mesothelial atypia diagnosed from peritoneal washings performed during risk-reducing salpingo-oophorectomy.

R. Barakat, D. Chi, O. Lin, 2006, Gynecologic oncology.

Phase I trial of intraperitoneal taxol: a Gynecoloic Oncology Group study.

R. Barakat, S. Rubin, J. Lewis, 1992, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

A prospective study of the feasibility and acceptability of a Web-based, electronic patient-reported outcome system in assessing patient recovery after major gynecologic cancer surgery.

E. Basch, R. Barakat, D. Chi, 2012, Gynecologic oncology.

Endometrial Carcinomas in Women Aged 40 Years and Younger: Tumors Associated With Loss of DNA Mismatch Repair Proteins Comprise a Distinct Clinicopathologic Subset

R. Barakat, A. Iasonos, K. Garg, 2009, The American journal of surgical pathology.

Fertility-sparing radical abdominal trachelectomy for cervical carcinoma: technique and review of the literature.

D. Levine, R. Barakat, D. Chi, 2006 .

Radical vaginal versus abdominal trachelectomy for stage IB1 cervical cancer: a comparison of surgical and pathologic outcomes.

R. Barakat, D. Chi, Kay J. Park, 2009, Gynecologic oncology.

Ventral hernia following primary laparotomy for ovarian, fallopian tube, and primary peritoneal cancers.

R. Barakat, D. Chi, K. Long, 2011, Gynecologic oncology.

Criteria for Using Intraperitoneal (IP) Chemotherapy for Advanced Ovarian Cancer

R. Barakat, 2010 .

Incidence of intestinal obstruction following intraperitoneal chemotherapy for ovarian tubal and peritoneal malignancies.

D. Levine, R. Barakat, D. Chi, 2009, Gynecologic oncology.

Prospective study of the correlation between postoperative computed tomography scan and primary surgeon assessment in patients with advanced ovarian, tubal, and peritoneal carcinoma reported to have undergone primary surgical cytoreduction to residual disease 1 cm or less.

Carol L. Brown, H. Hricak, D. Levine, 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Results of the 2006 Innsbruck International Consensus Conference on intraperitoneal chemotherapy in patients with ovarian cancer

R. Barakat, A. Gadducci, J. Sehouli, 2007, Cancer.

Aggressive surgery and ovarian cancer.

R. Barakat, D. Chi, 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Percutaneous endoscopic gastrostomy tube placement in patients with malignant bowel obstruction due to ovarian carcinoma.

R. Barakat, L. Ben-Porat, P. Sabbatini, 2005, Gynecologic oncology.

Salvage intraperitoneal therapy of small-volume residual ovarian cancer: impact of pretreatment finding of peritoneal carcinomatosis on the surgical complete response rate

R. Barakat, S. Rubin, M. Markman, 2005, Journal of Cancer Research and Clinical Oncology.

Impact of laparotomy finding of significant intraabdominal adhesions on the surgically defined complete response rate to subsequent salvage intraperitoneal chemotherapy

R. Barakat, S. Rubin, M. Markman, 2005, Journal of Cancer Research and Clinical Oncology.

Platinum-based chemotherapy for advanced-stage serous ovarian carcinoma of low malignant potential.

R. Barakat, P. Saigo, I. Benjamin, 1995, Gynecologic oncology.

Evidence supporting the superiority of intraperitoneal cisplatin compared to intraperitoneal carboplatin for salvage therapy of small-volume residual ovarian cancer.

R. Barakat, S. Rubin, J. Lewis, 1993, Gynecologic oncology.

Surgery for malignant gynecologic disease

R. Barakat, I. Benjamin, 1993, Current opinion in obstetrics & gynecology.

Dose escalation of paclitaxel with high-dose cyclophosphamide, with analysis of progenitor-cell mobilization and hematologic support of advanced ovarian cancer patients receiving rapidly sequenced high-dose carboplatin/cyclophosphamide courses.

R. Barakat, D. Spriggs, M. Moore, 1995, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Reoperation for palliation of recurrent malignant bowel obstruction in ovarian carcinoma.

R. Barakat, D. Chi, L. Meyer, 2004, Gynecologic oncology.

Carol L. Brown, D. Levine, R. Barakat, 2009, International Journal of Gynecologic Cancer.

Clinicopathologic features of early adenocarcinoma of the cervix initially managed with cervical conization.

R. Barakat, B. Slomovitz, R. Soslow, 2006, Gynecologic oncology.

Management and follow-up of patients with adenocarcinoma in situ of the uterine cervix.

R. Barakat, E. Poynor, W. Hoskins, 1995, Gynecologic oncology.

Impact of incorporating an algorithm that utilizes sentinel lymph node mapping during minimally invasive procedures on the detection of stage IIIC endometrial cancer.

R. Barakat, C. Brown, G. Gardner, 2013, Gynecologic oncology.

A 2-year prospective study assessing the emotional, sexual, and quality of life concerns of women undergoing radical trachelectomy versus radical hysterectomy for treatment of early-stage cervical cancer.

Carol L. Brown, R. Barakat, D. Chi, 2010, Gynecologic oncology.

Five-year outcomes of adjuvant carboplatin/paclitaxel chemotherapy and intravaginal radiation for stage I-II papillary serous endometrial cancer.

R. Barakat, C. Aghajanian, G. Gardner, 2012, Gynecologic oncology.

Platinum‐based chemotherapy of high‐risk stage I epithelial ovarian cancer following comprehensive surgical staging

R. Barakat, S. Rubin, G. Wong, 1993, Obstetrics and gynecology.

Impact on survival of surgically defined favorable responses to salvage intraperitoneal chemotherapy in small-volume residual ovarian cancer.

R. Barakat, S. Rubin, J. Lewis, 1992, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Intraperitoneal chemotherapy in the management of ovarian cancer

R. Barakat, P. Saigo, B. Mychalczak, 1993, Cancer.

Incidence of Venous Thromboembolism After Minimally Invasive Surgery in Patients With Newly Diagnosed Endometrial Cancer

Carol L. Brown, R. Barakat, G. Gardner, 2012, Obstetrics and gynecology.

Adjuvant radiation for early stage endometrial cancer with lymphovascular invasion.

R. Barakat, N. Abu-Rustum, V. Croog, 2008, Gynecologic oncology.

Surgical cytoreduction in patients with metastatic uterine leiomyosarcoma at the time of initial diagnosis.

R. Barakat, D. Chi, M. Leitao, 2012, Gynecologic oncology.

Incidence and management of pancreatic leaks after splenectomy with distal pancreatectomy performed during primary cytoreductive surgery for advanced ovarian, peritoneal and fallopian tube cancer.

R. Barakat, M. D'Angelica, W. Jarnagin, 2009, Gynecologic oncology.

Resection of recurrent ovarian or fallopian tube carcinoma involving the liver.

R. Barakat, W. Jarnagin, D. Chi, 2003, Gynecologic oncology.

Pelvic exenteration for recurrent endometrial cancer.

E. Venkatraman, R. Barakat, N. Goldman, 1999, Gynecologic oncology.

The role of surgical cytoreduction in Stage IV endometrial carcinoma.

E. Venkatraman, R. Barakat, D. Chi, 1997, Gynecologic oncology.

Intraperitoneal Taxol (paclitaxel) in the management of ovarian cancer.

R. Barakat, P. Francis, J. Lewis, 1994, Annals of oncology : official journal of the European Society for Medical Oncology.

Role of laparoscopy in the evaluation of the adnexa in patients with stage IV breast cancer.

R. Barakat, P. Borgen, M. Gemignani, 2004, Gynecologic oncology.

Ovarian disease in women with breast cancer

R. Barakat, J. Curtin, W. Hoskins, 1994, Obstetrics and gynecology.

Accuracy of frozen section diagnosis of ovarian borderline tumor.

R. Barakat, D. Chi, K. Garg, 2011, Gynecologic oncology.

Feasibility and perioperative outcomes of robotic-assisted surgery in the management of recurrent ovarian cancer: a multi-institutional study.

P. Escobar, R. Barakat, A. Fader, 2014, Gynecologic oncology.

Laparoscopic staging procedures

R. Barakat, Y. Sonoda, 2008 .

Use of an ureteroileocecal appendicostomy urinary reservoir in patients with recurrent pelvic malignancies treated with radiation.

D. Levine, R. Barakat, B. Bochner, 2004, Gynecologic oncology.

Continent urinary diversion and low-rectal anastomosis in patients undergoing exenterative procedures for recurrent gynecologic malignancies.

R. Barakat, J. Curtin, E. Poynor, 2000, Gynecologic oncology.

Surgical cytoreduction in stage IV endometrioid endometrial carcinoma.

R. Barakat, D. Chi, G. Gardner, 2011, Gynecologic oncology.

Postoperative intra-abdominal collections using a sodium hyaluronate-carboxymethylcellulose (HA-CMC) barrier at the time of laparotomy for ovarian, fallopian tube, or primary peritoneal cancers.

D. Levine, R. Barakat, D. Chi, 2009, Gynecologic oncology.

GOG 244 - The LymphEdema and Gynecologic cancer (LEG) study: The association between the gynecologic cancer lymphedema questionnaire (GCLQ) and lymphedema of the lower extremity (LLE).

D. Alberts, R. Barakat, A. Hutson, 2019, Gynecologic oncology.

Oncologic outcome of fertility-sparing radical trachelectomy versus radical hysterectomy for stage IB1 cervical carcinoma.

Carol L. Brown, R. Barakat, D. Chi, 2008, Gynecologic oncology.

Initial experience with Dargent's operation: the radical vaginal trachelectomy.

R. Barakat, D. Chi, Y. Sonoda, 2008, Gynecologic oncology.

Patterns of first recurrence following adjuvant intraperitoneal chemotherapy for stage IIIC ovarian cancer.

D. Levine, R. Barakat, F. Dao, 2012, Gynecologic oncology.

High-intensity intravenous cyclophosphamide and cisplatin, interim surgical debulking, and intraperitoneal cisplatin in advanced ovarian carcinoma: a pilot trial with ten-year follow-up.

E. Venkatraman, R. Barakat, D. Spriggs, 1997, Gynecologic oncology.

Phase 2 trial of intraperitoneal carboplatin and etoposide as salvage treatment of advanced epithelial ovarian cancer.

R. Barakat, J. Lewis, M. Markman, 1992, Gynecologic oncology.

Total laparoscopic radical hysterectomy with pelvic lymphadenectomy using the argon-beam coagulator: pilot data and comparison to laparotomy.

Carol L. Brown, E. Venkatraman, R. Barakat, 2003, Gynecologic oncology.

Clinical Outcome of Isolated Serous Tubal Intraepithelial Carcinomas (STIC)

Carol L. Brown, D. Levine, R. Barakat, 2013, International Journal of Gynecologic Cancer.

Fallopian Tube Cancer

R. Barakat, D. Black, 2006 .

Palliative surgery for bowel obstruction in recurrent ovarian cancer:an updated series.

E. Venkatraman, R. Barakat, D. Chi, 2003, Gynecologic oncology.

Parenchymal splenic metastasis is an independent negative predictor of overall survival in advanced ovarian, fallopian tube, and primary peritoneal cancer.

R. Barakat, D. Chi, E. Tanner, 2012, Gynecologic oncology.

Splenectomy in recurrent epithelial ovarian cancer.

R. Barakat, D. Chi, M. Gemignani, 1999, Gynecologic oncology.

Craniotomy for central nervous system metastases in epithelial ovarian carcinoma.

E. Venkatraman, M. Bilsky, R. Barakat, 2002, Gynecologic oncology.

Mixed mesodermal tumor of the ovary: Analysis of prognostic factors in 31 cases

R. Barakat, P. Saigo, S. Rubin, 1992, Obstetrics and gynecology.

Chemotherapy and total parenteral nutrition for advanced ovarian cancer with bowel obstruction.

E. Venkatraman, R. Barakat, D. Spriggs, 1997, Gynecologic oncology.

A prospective randomized trial comparing patient-controlled epidural analgesia to patient-controlled intravenous analgesia on postoperative pain control and recovery after major open gynecologic cancer surgery.

V. Seshan, D. Levine, R. Barakat, 2009, Gynecologic oncology.

Primary vaginal melanoma: A critical analysis of therapy

R. Barakat, K. Busam, R. Delgado, 2006, Annals of Surgical Oncology.

Micrometastasis of endometrial cancer to sentinel lymph nodes: is it an artifact of uterine manipulation?

R. Barakat, M. Murray, N. Abu-Rustum, 2010, Gynecologic oncology.

Postoperative external beam radiation therapy and concurrent cisplatin followed by carboplatin/paclitaxel for stage III (FIGO 2009) endometrial cancer.

R. Barakat, W. Tew, M. Kollmeier, 2013, Gynecologic oncology.

Distribution of radiolabeled monoclonal antibody MX35 F(ab')2 in tissue samples by storage phosphor screen image analysis: evaluation of antibody localization to micrometastatic disease in epithelial ovarian cancer.

J. Humm, S. Larson, R. Barakat, 1997, Clinical cancer research : an official journal of the American Association for Cancer Research.

Effect of perioperative venous thromboembolism on survival in ovarian, primary peritoneal, and fallopian tube cancer.

R. Barakat, D. Chi, A. Iasonos, 2007, Gynecologic oncology.

Pelvic insufficiency fractures in patients with cervical and endometrial cancer treated with postoperative pelvic radiation.

M. Folkert, R. Barakat, M. Leitao, 2013, Gynecologic oncology.

FrequentMutation of the PIK 3 CA Gene in Ovarian and Breast Cancers

A. Lash, D. Levine, R. Barakat, 2005 .

Principles and Practice of Gynecologic Oncology

R. Barakat, 2009 .

WNK1 haplotypes and bevacizumab-induced hypertension

L. Borsu, D. Levine, R. Barakat, 2008 .

Clinicopathologic significance of DNA mismatch repair protein defects and endometrial cancer in women 40years of age and younger.

D. Levine, R. Barakat, N. Kauff, 2011, Gynecologic oncology.

Gastrointestinal toxicity and Clostridium difficile diarrhea in patients treated with paclitaxel-containing chemotherapy regimens.

R. Barakat, D. Spriggs, A. Husain, 1998, Gynecologic oncology.

IV.6 Tamoxifen and endometrial cancer: most cancers are early stage and highly curable

R. Barakat, 1998 .

The use of colorectal stents for palliation of large-bowel obstruction due to recurrent gynecologic cancer.

R. Barakat, D. Chi, H. Gerdes, 2004, Gynecologic oncology.

Immunohistochemical expression of estrogen and progesterone receptors and outcomes in patients with newly diagnosed uterine leiomyosarcoma.

R. Barakat, C. Aghajanian, G. Gardner, 2012, Gynecologic oncology.

Intraoperative hypothermia during primary surgical cytoreduction for advanced ovarian cancer: risk factors and associations with postoperative morbidity.

D. Levine, R. Barakat, D. Chi, 2013, Gynecologic oncology.

Management of uterine malignancy found incidentally after supracervical hysterectomy or uterine morcellation for presumed benign disease

R. Barakat, D. Chi, M. Hensley, 2007, International Journal of Gynecologic Cancer.

The role of cytoreductive surgery for newly diagnosed advanced-stage uterine carcinosarcoma.

R. Barakat, D. Chi, E. Tanner, 2011, Gynecologic oncology.

Gynecologic cancer treatment and the impact of cancer-related infertility.

R. Barakat, D. Chi, J. Carter, 2005, Gynecologic oncology.

Radical surgical resection and high-dose intraoperative radiation therapy (HDR-IORT) in patients with recurrent gynecologic cancers.

R. Barakat, B. Mychalczak, M. Gemignani, 2000, International journal of radiation oncology, biology, physics.

Squamous cell carcinoma arising in mature cystic teratoma of the ovary: a case series and review of the literature.

R. Barakat, A. Iasonos, C. Aghajanian, 2007, Gynecologic oncology.

Use of hormone suppression then oocyte freezing to preserve reproductive capability in an adolescent girl with ovarian luteinized thecoma associated with sclerosing peritonitis.

R. Barakat, M. Fino, N. Noyes, 2009, Fertility and sterility.

Peritoneal Washings in Endometrial Carcinoma

M. Gu, W. Shi, R. Barakat, 2000, Acta Cytologica.

Tissue microarray immunohistochemical expression of estrogen, progesterone, and androgen receptors in uterine leiomyomata and leiomyosarcoma

A. Olshen, R. Barakat, P. Sabbatini, 2004, Cancer.

Handbook of Gynecologic Oncology

R. Barakat, D. Gershenson, W. Hoskins, 2002 .

Clinicopathologic Features of Rhabdomyosarcoma of Gynecologic Origin in Adults

W. Gerald, R. Barakat, D. Chi, 2007, The American journal of surgical pathology.

Frequent Mutation of the PIK3CA Gene in Ovarian and Breast Cancers

A. Lash, D. Levine, J. Boyd, 2005, Clinical Cancer Research.

Genetic Analysis of the Early Natural History of Epithelial Ovarian Carcinoma

Adam B. Olshen, Mark E. Robson, Kenneth Offit, 2010, PloS one.

Gemcitabine and docetaxel in patients with unresectable leiomyosarcoma: results of a phase II trial.

E. Venkatraman, R. Barakat, R. Maki, 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Risk-reducing salpingo-oophorectomy for the prevention of BRCA1- and BRCA2-associated breast and gynecologic cancer: a multicenter, prospective study.

T. Rebbeck, R. Eeles, C. Hudis, 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

A microRNA survival signature (MiSS) for advanced ovarian cancer.

L. Qin, A. Viale, D. Levine, 2011, Gynecologic oncology.

Molecular Pathogenesis of Endometrial Cancer

R. Barakat, Y. Sonoda, 2000 .

Intrinsic resistance of cervical squamous cell carcinoma cell lines to methotrexate (MTX) as a result of decreased accumulation of intracellular MTX polyglutamates.

R. Barakat, J. Bertino, W. Li, 1993, Gynecologic oncology.

Fallopian tube and primary peritoneal carcinomas associated with BRCA mutations.

K. Offit, D. Levine, J. Boyd, 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Strongly with the Clinical Course of Epithelial Ovarian Cancer Has Features of an Oncogene and Its Overexpression Correlates

G. Pavesi, D. Katsaros, R. Barakat, 2015 .

Validated gene targets associated with curatively treated advanced serous ovarian carcinoma.

D. Levine, R. Barakat, F. Dao, 2012, Gynecologic oncology.

Lysophosphatidic acid acyltransferase‐β (LPAAT‐β) is highly expressed in advanced ovarian cancer and is associated with aggressive histology and poor survival

R. Barakat, A. Iasonos, C. Hedvat, 2006 .

Frozen-section evaluation of cervical adenocarcinoma at time of radical trachelectomy: pathologic pitfalls and the application of an objective scoring system.

R. Barakat, R. Soslow, Kay J. Park, 2008, Gynecologic oncology.

The feasibility and safety of same-day discharge after robotic-assisted hysterectomy alone or with other procedures for benign and malignant indications.

R. Barakat, G. Gardner, M. Leitao, 2014, Gynecologic oncology.

Risk of endometrial carcinoma associated with BRCA mutation.

J. Satagopan, K. Offit, D. Levine, 2001, Gynecologic oncology.

Exploratory analysis of serum CA-125 response to surgery and the risk of relapse in patients with FIGO stage IIIC ovarian cancer.

C. Sima, D. Levine, R. Barakat, 2009, Gynecologic oncology.

The effect of maximal surgical cytoreduction on sensitivity to platinum-taxane chemotherapy and subsequent survival in patients with advanced ovarian cancer.

R. Barakat, D. Chi, C. Aghajanian, 2008, Gynecologic oncology.

Platinum resistance and impaired survival in patients with advanced primary peritoneal carcinoma: matched-case comparison with patients with epithelial ovarian carcinoma.

D. Levine, R. Barakat, D. Chi, 2008, American journal of obstetrics and gynecology.

Response and outcomes in elderly patients with stages IIIC-IV ovarian cancer receiving platinum-taxane chemotherapy.

D. Levine, R. Barakat, D. Chi, 2007, Gynecologic oncology.

CA125 level as a predictor of progression-free survival and overall survival in ovarian cancer patients with surgically defined disease status prior to the initiation of intraperitoneal consolidation therapy.

Alexia Iasonos, Paul Sabbatini, R. Barakat, 2007, Gynecologic oncology.

The addition of extensive upper abdominal surgery to achieve optimal cytoreduction improves survival in patients with stages IIIC-IV epithelial ovarian cancer.

D. Levine, R. Barakat, M. D'Angelica, 2006, Gynecologic oncology.

Recurrence and survival after random assignment to laparoscopy versus laparotomy for comprehensive surgical staging of uterine cancer: Gynecologic Oncology Group LAP2 Study.

R. Barakat, R. Mannel, Joan L. Walker, 2012, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Colorectal Stents for Palliation of Large-Bowel Obstructions in Recurrent Gynecologic Cancer: An Updated Series

R. Barakat, D. Chi, A. Iasonos, 2008 .

What is the optimal goal of primary cytoreductive surgery for bulky stage IIIC epithelial ovarian carcinoma (EOC)

D. Levine, R. Barakat, D. Chi, 2006 .

Gene expression profiling of tamoxifen-associated uterine cancers: evidence for two molecular classes of endometrial carcinoma.

A. Olshen, A. Viale, J. Boyd, 2004, Gynecologic oncology.

Full-thickness diaphragmatic resection for stage IV ovarian carcinoma using the EndoGIA stapling device followed by diaphragmatic reconstruction using a Gore-tex graft: a case report and review of the literature.

R. Barakat, W. Jarnagin, D. Chi, 2006, Gynecologic oncology.

Weight change during chemotherapy as a potential prognostic factor for stage III epithelial ovarian carcinoma: a Gynecologic Oncology Group study.

D. Alberts, R. Barakat, R. Ozols, 2007, Gynecologic oncology.

Reproductive outcomes of patients undergoing radical trachelectomy for early-stage cervical cancer.

R. Barakat, D. Chi, G. Gardner, 2011, Gynecologic oncology.

Improved progression-free and overall survival in advanced ovarian cancer as a result of a change in surgical paradigm.

D. Levine, R. Barakat, D. Chi, 2009, Gynecologic oncology.

Paclitaxel and carboplatin in the treatment of advanced or recurrent endometrial cancer: a large retrospective study

R. Barakat, P. Sabbatini, J. Dupont, 2006, International Journal of Gynecologic Cancer.

A nomogram to predict postresection 5‐year overall survival for patients with uterine leiomyosarcoma

Alexia Iasonos, Murray F. Brennan, L. Jacks, 2012, Cancer.

Stage-specific outcomes of patients with uterine leiomyosarcoma: a comparison of the international Federation of gynecology and obstetrics and american joint committee on cancer staging systems.

L. Jacks, R. Barakat, D. Chi, 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Expanding the Indications for Radical Trachelectomy: A Report on 29 Patients With Stage IB1 Tumors Measuring 2 to 4 Centimeters

R. Barakat, D. Chi, W. Tew, 2013, International Journal of Gynecologic Cancer.

Comparison of D&C and office endometrial biopsy accuracy in patients with FIGO grade 1 endometrial adenocarcinoma.

R. Barakat, D. Chi, M. Leitao, 2009, Gynecologic oncology.

Retroperitoneal nodal metastasis in primary and recurrent granulosa cell tumors of the ovary.

R. Barakat, D. Chi, P. Sabbatini, 2006, Gynecologic oncology.

Cisplatin-based combination chemotherapy in carcinoma of the fallopian tube.

R. Barakat, P. Saigo, S. Rubin, 1991, Gynecologic oncology.

Is there a difference in outcome between stage I-II endometrial cancer of papillary serous/clear cell and endometrioid FIGO Grade 3 cancer?

Brady J. McKee, E. Venkatraman, M. Zelefsky, 2002, International journal of radiation oncology, biology, physics.

Prevention of Gynecologic Malignancies

D. Alberts, L. Minasian, L. Brinton, 2004 .

Laparoscopic Management of Adnexal Masses in Women With a History of Nongynecologic Malignancy

R. Barakat, D. Chi, J. Curtin, 1995, Obstetrics and gynecology.

Treatment patterns of FIGO Stage IB2 cervical cancer: a single-institution experience of radical hysterectomy with individualized postoperative therapy and definitive radiation therapy.

R. Barakat, D. Chi, A. Iasonos, 2008, Gynecologic oncology.

Pilot study prospectively evaluating the use of the measurement of preoperative sonographic endometrial thickness in postmenopausal patients with endometrial cancer

E. Venkatraman, R. Barakat, D. Chi, 2005, Menopause.

Association between initial diagnostic procedure and hysteroscopy and abnormal peritoneal washings in patients with endometrial carcinoma

M. Gu, W. Shi, R. Barakat, 2000, Cancer.

Pathologic Ultrastaging Improves Micrometastasis Detection in Sentinel Lymph Nodes During Endometrial Cancer Staging

R. Barakat, R. Soslow, M. Hensley, 2013, International Journal of Gynecologic Cancer.

The importance of applying a sentinel lymph node mapping algorithm in endometrial cancer staging: beyond removal of blue nodes.

R. Barakat, D. Chi, D. DeLair, 2012, Gynecologic oncology.

High incidence of positive peritoneal cytology in low-risk endometrial cancer treated by laparoscopically assisted vaginal hysterectomy.

R. Barakat, O. Lin, Y. Sonoda, 2001, Gynecologic oncology.

Impact of Obesity on Sentinel Lymph Node Mapping in Patients with Newly Diagnosed Uterine Cancer Undergoing Robotic Surgery

D. Levine, R. Barakat, G. Gardner, 2015, Annals of Surgical Oncology.

A pilot study using the Gynecologic Cancer Lymphedema Questionnaire (GCLQ) as a clinical care tool to identify lower extremity lymphedema in gynecologic cancer survivors.

R. Barakat, A. Iasonos, R. Baser, 2010, Gynecologic oncology.

Sexual health needs and educational intervention preferences for women with cancer

R. Barakat, R. Baser, M. Dickler, 2017, Breast Cancer Research and Treatment.

Contemporary quality of life issues affecting gynecologic cancer survivors.

R. Barakat, L. Wenzel, R. Penson, 2012, Hematology/oncology clinics of North America.

Allergy to latex surgical gloves: an unfamiliar cause of intraoperative anaphylaxis.

R. Barakat, W. Hoskins, G. Shepherd, 1992, Gynecologic oncology.

CASE REPORT Allergy to Latex Surgical Gloves: An Unfamiliar Cause of lntraoperative Anaphylaxis

R. Barakat, W. Hoskins, G. Shepherd, 1992 .

Postoperative Pain Medication Requirements in Patients Undergoing Computer-Assisted (“Robotic”) and Standard Laparoscopic Procedures for Newly Diagnosed Endometrial Cancer

R. Barakat, G. Gardner, M. Leitao, 2013, Annals of Surgical Oncology.

Risk of ovarian cancer in BRCA1 and BRCA2 mutation-negative hereditary breast cancer families.

Nandita Mitra, Kenneth Offit, Tessa Cigler, 2005, Journal of the National Cancer Institute.

Ovarian carcinoma screening in women at intermediate risk

K. Offit, R. Barakat, M. Robson, 2005, Cancer.

Four-year follow-up of outcomes following risk-reducing salpingo-oophorectomy in BRCA mutation carriers

C. Hudis, K. Offit, J. Boyd, 2005 .

Risk-reducing salpingo-oophorectomy in women with a BRCA1 or BRCA2 mutation.

J. Satagopan, C. Hudis, L. Norton, 2002, The New England journal of medicine.

Pretreatment of endometrial carcinoma cell lines with butyrate results in upregulation of Bax and correlates with potentiation of radiation induced cell kill.

R. Barakat, D. Banerjee, J. Bertino, 2000, In vivo.

Survival in epithelial ovarian cancer: a multivariate analysis incorporating BRCA mutation status and platinum sensitivity.

K. Offit, R. Barakat, P. Sabbatini, 2011, Annals of oncology : official journal of the European Society for Medical Oncology.

Surgical risk-reduction in carriers of BRCA mutations: where do we go from here?

R. Barakat, N. Kauff, 2004, Gynecologic oncology.

Outcome of preventive surgery and screening for breast and ovarian cancer in BRCA mutation carriers.

J. Satagopan, L. Norton, K. Offit, 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Early postoperative CT as a prognostic biomarker in patients with advanced ovarian, tubal, and primary peritoneal cancer deemed optimally debulked at primary cytoreductive surgery.

H. Hricak, O. Akin, R. Barakat, 2012, AJR. American journal of roentgenology.

An analysis of patients with bulky advanced stage ovarian, tubal, and peritoneal carcinoma treated with primary debulking surgery (PDS) during an identical time period as the randomized EORTC-NCIC trial of PDS vs neoadjuvant chemotherapy (NACT).

D. Levine, R. Barakat, F. Dao, 2012, Gynecologic oncology.

Follow-Up Study of the Correlation Between Postoperative Computed Tomographic Scan and Primary Surgeon Assessment in Patients With Advanced Ovarian, Tubal, or Peritoneal Carcinoma Reported to Have Undergone Primary Surgical Cytoreduction to Residual Disease of 1 cm or Smaller

H. Hricak, R. Barakat, F. Dao, 2009, International Journal of Gynecologic Cancer.

Concurrent carboplatin/paclitaxel and intravaginal radiation in surgical stage I-II serous endometrial cancer.

R. Barakat, D. Chi, C. Aghajanian, 2009, Gynecologic oncology.

Identification of prognostic factors after positive second-look surgery in epithelial ovarian carcinoma.

E. Venkatraman, R. Barakat, D. Chi, 2006, Gynecologic oncology.

Guidelines and selection criteria for secondary cytoreductive surgery in patients with recurrent, platinum‐sensitive epithelial ovarian carcinoma

E. Venkatraman, R. Barakat, D. Chi, 2006, Cancer.

Intravaginal brachytherapy alone for intermediate-risk endometrial cancer.

E. Venkatraman, R. Barakat, D. Chi, 2005, International journal of radiation oncology, biology, physics.

Is endometrial carcinoma intrinsically more aggressive in elderly patients?

E. Venkatraman, R. Barakat, N. Abu-Rustum, 2003, Cancer.

The significance of the amount of myometrial invasion in patients with Stage IB endometrial carcinoma

Brady J. McKee, E. Venkatraman, M. Zelefsky, 2002, Cancer.

Intravaginal high-dose-rate brachytherapy for Stage IB (FIGO Grade 1, 2) endometrial cancer.

Brady J. McKee, E. Venkatraman, R. Barakat, 2002, International journal of radiation oncology, biology, physics.

A phase II trial of intraperitoneal cisplatin and etoposide as consolidation therapy in patients with Stage II-IV epithelial ovarian cancer following negative surgical assessment.

E. Venkatraman, R. Barakat, C. Brown, 1998, Gynecologic oncology.

Laparoscopic-assisted vaginal hysterectomy for endometrial cancer: clinical outcomes and hospital charges.

E. Venkatraman, R. Barakat, M. Gemignani, 1999, Gynecologic oncology.

Clinicopathologic Analysis of Early-stage Sporadic Ovarian Carcinoma

E. Venkatraman, J. Boyd, R. Barakat, 2004, The American journal of surgical pathology.

Fallopian T ube a nd P rimary P eritoneal C arcinomas A ssociated With BRCA Mutations

K. Offit, D. Levine, J. Boyd, 2003 .

A Prospective Randomized Trial Comparing Patient-Controlled Epidural Analgesia to Patient-Controlled Intravenous Analgesia on Postoperative Pain Control and Recovery After Major Open Gynecologic Cancer Surgery

V. Seshan, D. Levine, R. Barakat, 2009 .

Phase II study of "dose-dense" high-dose chemotherapy treatment with peripheral-blood progenitor-cell support as primary treatment for patients with advanced ovarian cancer.

E. Venkatraman, L. Norton, R. Barakat, 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Preoperative serum YKL-40 is a marker for detection and prognosis of endometrial cancer.

D. Levine, R. Barakat, H. Thaler, 2007, Gynecologic oncology.

Treatment effects, disease recurrence, and survival in obese women with early endometrial carcinoma

R. Barakat, S. Waggoner, C. Tian, 2006, Cancer.

Phase 2 trial of chronic low-dose oral etoposide as salvage therapy of platinum-refractory ovarian cancer

R. Barakat, S. Rubin, M. Markman, 2005, Journal of Cancer Research and Clinical Oncology.

Sexual functioning among endometrial cancer patients treated with adjuvant high-dose-rate intra-vaginal radiation therapy.

E. Basch, A. Bennett, R. Barakat, 2012, International journal of radiation oncology, biology, physics.

Clinicopathologic significance of defective DNA mismatch repair in endometrial carcinoma.

D. Levine, J. Boyd, R. Barakat, 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Role of KRAS and BRAF gene mutations in mucinous ovarian carcinoma.

Oscar Lin, J. Boyd, R. Barakat, 2003, Gynecologic oncology.

Comparing Surgical Outcomes in Obese Women Undergoing Laparotomy, Laparoscopy, or Laparotomy With Panniculectomy for the Staging of Uterine Malignancy

R. Barakat, D. Chi, B. Mehrara, 2007, Annals of Surgical Oncology.

Re: The Revised 2009 FIGO Staging System for Endometrial Cancer

R. Barakat, K. Wen, D. Chi, 2012, International Journal of Gynecologic Cancer.

Prognostic Value of Lymph Node Ratio and Clinicopathologic Parameters in Patients Diagnosed With Stage IIIC Endometrial Cancer

R. Barakat, N. Concin, A. Reinthaller, 2012, Obstetrics and gynecology.

Surgical resection of recurrent endometrial carcinoma.

Amanda J Hummer, R. Barakat, D. Chi, 2006, Gynecologic oncology.

Postoperative pelvic intensity-modulated radiotherapy in high risk endometrial cancer.

R. Barakat, G. Gardner, W. Tew, 2013, Gynecologic oncology.

Postoperative pelvic intensity-modulated radiotherapy and concurrent chemotherapy in intermediate- and high-risk cervical cancer.

M. Folkert, R. Barakat, M. Kollmeier, 2013, Gynecologic oncology.

Incidence and management of bevacizumab-associated gastrointestinal perforations in patients with recurrent ovarian carcinoma.

R. Barakat, D. Chi, P. Sabbatini, 2010, Gynecologic oncology.

The incidence of pelvic lymph node metastasis by FIGO staging for patients with adequately surgically staged endometrial adenocarcinoma of endometrioid histology

D. Levine, R. Barakat, D. Chi, 2007, International Journal of Gynecologic Cancer.

Palliative benefit of external-beam radiation in the management of platinum refractory epithelial ovarian carcinoma.

R. Barakat, B. Mychalczak, D. Spriggs, 1998, Gynecologic oncology.

Stratification of Intermediate-Risk Endometrial Cancer Patients into Groups at High Risk or Low Risk for Recurrence Based on Tumor Gene Expression Profiles

Adam B. Olshen, A. Olshen, A. Viale, 2005, Clinical Cancer Research.

Risk-reducing salpingo-oophorectomy in women with a BRCA1 or BRCA2 mutation

Mark E. Robson, Kenneth Offit, Jaya M. Satagopan, 2002 .

Ten-year experience with laparoscopy on a gynecologic oncology service: analysis of risk factors for complications and conversion to laparotomy.

E. Venkatraman, R. Barakat, D. Chi, 2004, American journal of obstetrics and gynecology.

Patients with a history of epithelial ovarian cancer presenting with a breast and/or axillary mass.

R. Barakat, M. Morrow, M. Stempel, 2009, Gynecologic oncology.

Plastic reconstructive procedures

P. Cordeiro, R. Barakat, A. Pusic, 2018, An Atlas of Gynecologic Oncology.

Video-assisted thoracic surgery (VATS) evaluation of pleural effusions in patients with newly diagnosed advanced ovarian carcinoma can influence the primary management choice for these patients.

R. Barakat, D. Chi, R. Flores, 2010, Gynecologic oncology.

Ureteroileocecal appendicostomy based urinary reservoir in irradiated and nonirradiated patients.

R. Barakat, B. Bochner, D. Chi, 2009, The Journal of urology.

Impact of Robotic Platforms on Surgical Approach and Costs in the Management of Morbidly Obese Patients with Newly Diagnosed Uterine Cancer

D. Levine, R. Barakat, D. Chi, 2016, Annals of Surgical Oncology.

Screening and the prevention of gynecologic cancer: endometrial cancer.

R. Barakat, Y. Sonoda, 2006, Best practice & research. Clinical obstetrics & gynaecology.

Clinicopathologic features of bone metastases and outcomes in patients with primary endometrial cancer.

R. Barakat, R. Soslow, S. Ferguson, 2010, Gynecologic oncology.

Effects of Tamoxifen on Cervicovaginal Smears from Patients with Breast Cancer

R. Barakat, P. Saigo, M. Abadi, 2000, Acta Cytologica.

A prospective outcomes analysis of palliative procedures performed for malignant intestinal obstruction due to recurrent ovarian cancer.

R. Barakat, D. Chi, G. Gardner, 2009, The oncologist.

Ovarian and Uterine Disease in Women with Colorectal Cancer

R. Barakat, J. Curtin, N. Abu-Rustum, 1997, Obstetrics and gynecology.

Tamoxifen and endometrial neoplasia.

R. Barakat, 1996, Clinical obstetrics and gynecology.

The effect of tamoxifen on the endometrium.

R. Barakat, R R Barakat, 1995, Oncology.

Ligation of an anatomic variant of renal vasculature during laparoscopic periaortic lymph node dissection: a cause of postoperative renal infarction.

R. Barakat, Joan L. Walker, N. Abu-Rustum, 2003, Gynecologic oncology.

Mesorectal lymph node involvement and prognostic implications at total pelvic exenteration for gynecologic malignancies.

E. Venkatraman, R. Barakat, D. Chi, 2006, Gynecologic oncology.

A prospective study of quality of life in patients undergoing pelvic exenteration: interim results.

R. Barakat, B. Bochner, F. Dao, 2013, Gynecologic oncology.

Brief report: Total pelvic exenteration‐A retrospective clinical needs assessment

R. Barakat, D. Chi, J. Carter, 2004, Psycho-oncology.

Clinical Approach to Diagnosis and Management of Endometrial Hyperplasia and Carcinoma.

R. Barakat, M. Leitao, 2011, Surgical pathology clinics.

Borderline tumors of the ovary.

R. Barakat, 1994, Obstetrics and gynecology clinics of North America.

Epithelial ovarian carcinoma and European birthplace of grandparents.

R. Barakat, S. Olson, T. Caputo, 2001, Gynecologic oncology.

The use of recombinant human erythropoietin to prevent carboplatin-induced anemia.

R. Barakat, J. Lewis, M. Markman, 1993, Gynecologic oncology.

Cytoreductive surgery: intestinal tract and omentum

R. Barakat, D. Chi, Y. Sonoda, 2005 .

Postoperative intra-abdominal collections using a sodium hyaluronate-carboxymethylcellulose (HA-CMC) barrier at the time of laparotomy for uterine or cervical cancers.

D. Levine, R. Barakat, D. Chi, 2010, Gynecologic oncology.

Optimal (≤1 cm) but visible residual disease: is extensive debulking warranted?

D. Levine, R. Barakat, D. Chi, 2013, Gynecologic oncology.

Cystoscopic temporary ureteral catheterization during radical vaginal and abdominal trachelectomy.

R. Barakat, D. Chi, Y. Sonoda, 2006, Gynecologic oncology.

Surgical and pathologic outcomes of fertility-sparing radical abdominal trachelectomy for FIGO stage IB1 cervical cancer.

R. Barakat, D. Chi, M. Gemignani, 2008, Gynecologic oncology.

A fertility-sparing alternative to radical hysterectomy: how many patients may be eligible?

R. Barakat, D. Chi, M. Gemignani, 2004, Gynecologic oncology.

Extended pelvic resections for recurrent or persistent uterine and cervical malignancies: an update on out of the box surgery.

R. Barakat, B. Bochner, D. Chi, 2012, Gynecologic oncology.

Herniation formation in women undergoing robotically assisted laparoscopy or laparotomy for endometrial cancer.

R. Barakat, D. Chi, G. Gardner, 2016, Gynecologic oncology.

Cervical Conization and Sentinel Lymph Node Mapping in the Treatment of Stage I Cervical Cancer: Is Less Enough?

R. Barakat, D. Chi, Kay J. Park, 2013, International Journal of Gynecologic Cancer.

Radical Surgery With Individualized Postoperative Radiation for Stage IB Cervical Cancer: Oncologic Outcomes and Severe Complications

R. Barakat, D. Chi, E. Tanner, 2013, International Journal of Gynecologic Cancer.

Laparoscopic and hand-assisted laparoscopic splenectomy for recurrent and persistent ovarian cancer.

R. Barakat, M. D'Angelica, D. Chi, 2006, Gynecologic oncology.

Feasibility of Adjuvant Chemotherapy After Pelvic Exenteration for Gynecologic Malignancies

R. Barakat, D. Chi, W. Tew, 2013, International Journal of Gynecologic Cancer.

The effects of CO2 pneumoperitoneum on the survival of women with persistent metastatic ovarian cancer.

E. Venkatraman, R. Barakat, D. Chi, 2003, Gynecologic oncology.

Staging and surgical treatment.

R. Barakat, M. Leitao, 2009, Cancer treatment and research.

Exploring the use of chronic low-dose oral etoposide in ovarian cancer: is there a role for this "new drug" in the management of platinum-refractory disease?

R. Barakat, J. Lewis, M. Markman, 1992, Seminars in oncology.

Prognostic Significance of Supradiaphragmatic Lymphadenopathy Identified on Preoperative Computed Tomography Scan in Patients Undergoing Primary Cytoreduction for Advanced Epithelial Ovarian Cancer

H. Hricak, D. Levine, R. Barakat, 2010, International Journal of Gynecologic Cancer.

Postoperative outcomes among patients undergoing thoracostomy tube placement at time of diaphragm peritonectomy or resection during primary cytoreductive surgery for ovarian cancer.

D. Levine, R. Barakat, D. Chi, 2013, Gynecologic oncology.

The incidence of major complications after the performance of extensive upper abdominal surgical procedures during primary cytoreduction of advanced ovarian, tubal, and peritoneal carcinomas.

D. Levine, R. Barakat, D. Chi, 2010, Gynecologic oncology.

Minimal access surgery compared to laparotomy for secondary surgical cytoreduction in patients with recurrent ovarian carcinoma: Perioperative and oncologic outcomes.

R. Barakat, D. Chi, G. Gardner, 2017, Gynecologic oncology.

Positive peritoneal cytology is highly predictive of prognosis and relapse patterns in stage III (FIGO 2009) endometrial cancer.

R. Barakat, G. Gardner, M. Kollmeier, 2013, Gynecologic oncology.

Endometrial Cancer Prevention

R. Barakat, M. Leitao, 2019, Fundamentals of Cancer Prevention.

Randomized double-blind trial of estrogen replacement therapy versus placebo in stage I or II endometrial cancer: a Gynecologic Oncology Group Study.

R. Barakat, R. Mannel, B. Bundy, 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Impact of age on survival of patients with ovarian cancer.

R. Barakat, J. Lewis, M. Markman, 1993, Gynecologic oncology.

The clinical significance of malignant pleural effusions in patients with optimally debulked ovarian carcinoma

D. Levine, R. Barakat, D. Chi, 2005, Cancer.

Uterine Cancer After Risk-Reducing Salpingo-oophorectomy Without Hysterectomy in Women With BRCA Mutations.

M. Pike, T. Rebbeck, R. Eeles, 2016, JAMA oncology.

Tertiary cytoreduction in patients with recurrent epithelial ovarian, fallopian tube, or primary peritoneal cancer: an updated series.

R. Barakat, D. Chi, M. Leitao, 2010, Gynecologic oncology.

Beyond tertiary cytoreduction in patients with recurrent epithelial ovarian, fallopian tube, or primary peritoneal cancer.

R. Barakat, D. Chi, M. Leitao, 2010, Gynecologic oncology.

Patterns of relapse in stage I-II uterine papillary serous carcinoma treated with adjuvant intravaginal radiation (IVRT) with or without chemotherapy.

R. Barakat, M. Kollmeier, N. Abu-Rustum, 2013, Gynecologic oncology.

Tertiary cytoreduction in patients with recurrent ovarian carcinoma.

R. Barakat, D. Chi, M. Leitao, 2004, Gynecologic oncology.

Prognostic factors for patients with stage IV epithelial ovarian cancer receiving intraperitoneal chemotherapy after second‐look assessment

D. Levine, R. Barakat, P. Sabbatini, 2008, Cancer.

Twelve-year experience in the management of endometrial cancer: a change in surgical and postoperative radiation approaches.

R. Barakat, D. Chi, A. Hummer, 2007, Gynecologic oncology.

Racial disparities in recurrence among patients with early‐stage endometrial cancer

R. Barakat, C. Tian, C. Hamilton, 2008, Cancer.

Quantifying the risk of recurrence and death in stage III (FIGO 2009) endometrial cancer.

R. Barakat, M. Kollmeier, S. Milgrom, 2014, Gynecologic oncology.

Tumoral Displacement into Fallopian Tubes in Patients Undergoing Robotically Assisted Hysterectomy for Newly Diagnosed Endometrial Cancer

R. Barakat, D. DeLair, G. Gardner, 2013, International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists.

Molecular profiling of endometrial cancers from African-American and Caucasian women.

A. Olshen, A. Viale, D. Levine, 2006, Gynecologic oncology.

Intraperitoneal chemotherapy for ovarian carcinoma: results of long-term follow-up.

E. Venkatraman, S. Soignet, R. Barakat, 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Complications associated with intraperitoneal chemotherapy catheters.

R. Barakat, P. Sabbatini, D. Spriggs, 2001, Gynecologic oncology.

Superior pubic rami resection for isolated recurrent uterine cancer.

R. Barakat, D. Chi, P. Boland, 2007, Gynecologic oncology.

Pap Smears in Women with Endometrial Carcinoma

M. Gu, W. Shi, R. Barakat, 2001, Acta Cytologica.

Impact of operative start time on surgical outcomes in patients undergoing primary cytoreduction for advanced ovarian cancer.

R. Barakat, D. Chi, A. Iasonos, 2012, Gynecologic oncology.

The safety and efficacy of laparoscopic surgical staging of apparent stage I ovarian and fallopian tube cancers.

D. Levine, R. Barakat, D. Chi, 2005, American journal of obstetrics and gynecology.

Nomogram for survival after primary surgery for bulky stage IIIC ovarian carcinoma.

M. Kattan, R. Barakat, D. Chi, 2008, Gynecologic oncology.

Risk of Endometrial Carcinoma Associated With BRCA Mutation

J. Satagopan, K. Offit, D. Levine, 2001 .

A nomogram for predicting overall survival of women with endometrial cancer following primary therapy: toward improving individualized cancer care.

D. Levine, R. Barakat, D. Chi, 2010, Gynecologic oncology.

Patterns of recurrence in 1988 FIGO stage IC endometrioid endometrial cancer.

R. Barakat, D. Chi, K. Long, 2012, Gynecologic oncology.

Phase II trial of zeniplatin (CL 286 558), a new patinum compound, in patients with advanced ovarian cancer previously treated with organoplatinum-based therapy

R. Barakat, S. Rubin, M. Markman, 2005, Journal of Cancer Research and Clinical Oncology.

Benign and hyperplastic endometrial changes associated with tamoxifen use.

R. Barakat, 1997, Oncology.

Nomogram for predicting 5-year disease-specific mortality after primary surgery for epithelial ovarian cancer.

M. Kattan, E. Hill, D. Levine, 2012, Gynecologic oncology.

Intraperitoneal cisplatin and intravenous paclitaxel in the treatment of epithelial ovarian cancer patients with a positive second look.

E. Venkatraman, R. Barakat, P. Sabbatini, 2000, Gynecologic Oncology.

Is there a therapeutic impact to regional lymphadenectomy in the surgical treatment of endometrial carcinoma?

R. Barakat, D. Chi, A. Iasonos, 2008, American journal of obstetrics and gynecology.

Classification and regression tree (CART) analysis of endometrial carcinoma: Seeing the forest for the trees.

Alexia Iasonos, Qin Zhou, R. Barakat, 2013, Gynecologic oncology.

A contemporary analysis of the ability of preoperative serum CA-125 to predict primary cytoreductive outcome in patients with advanced ovarian, tubal and peritoneal carcinoma.

D. Levine, R. Barakat, D. Chi, 2009, Gynecologic oncology.

GOG 244 - The Lymphedema and Gynecologic cancer (LeG) study: The impact of lower-extremity lymphedema on quality of life, psychological adjustment, physical disability, and function.

W. E. Richards, D. Alberts, R. Barakat, 2020, Gynecologic oncology.

Observations on the role of circumflex iliac node resection and the etiology of lower extremity lymphedema following pelvic lymphadenectomy for gynecologic malignancy.

R. Barakat, N. Abu-Rustum, 2007, Gynecologic oncology.

Redefining Stage I Endometrial Cancer: Incorporating Histology, a Binary Grading System, Myometrial Invasion, and Lymph Node Assessment

R. Barakat, A. Iasonos, X. Matías-Guiu, 2013, International Journal of Gynecologic Cancer.

GOG 244, the lymphedema and gynecologic cancer (LEG) study: Incidence and risk factors in newly diagnosed patients

W. E. Richards, R. Barakat, J. Kauderer, 2018, Gynecologic Oncology.

Nanometastases of Endometrial Carcinoma to Sentinel Lymph Nodes: The Contribution of Pathologic Ultrastaging

R. Barakat, D. Chi, M. Hensley, 2012 .

Incidence of sentinel lymph node metastasis in endometrial carcinoma: Correlation with tumor grade and myometrial invasion

R. Barakat, D. Chi, M. Leitao, 2012 .

Sentinel lymph node mapping for grade 1/2 endometrial cancer with superficial myoinvasion: Less is more

D. Levine, R. Barakat, D. Chi, 2011 .

The value of MR imaging when the site of uterine cancer origin is uncertain.

H. Hricak, O. Akin, H. Vargas, 2011, Radiology.

Development of Endometrial Cancer After Radiation Treatment for Cervical Carcinoma

E. Venkatraman, R. Barakat, L. Ramondetta, 2003, Obstetrics and gynecology.

Pelvic cytoreduction with rectosigmoid resection.

R. Barakat, M. Juretzka, 2007, Gynecologic Oncology.

The Zinc Finger Gene ZIC2 Has Features of an Oncogene and Its Overexpression Correlates Strongly with the Clinical Course of Epithelial Ovarian Cancer

D. Katsaros, R. Barakat, G. Cattoretti, 2012, Clinical Cancer Research.

Laparotomy to Complete Staging of Presumed Early Ovarian Cancer

R. Barakat, E. Stier, J. Curtin, 1996, Obstetrics and gynecology.

Is there a difference in outcome between stage I-II endometrial cancer of papillary serous (PS)/clear cell (CC) histologies and endometrioid FIGO grade 3

Brady J. McKee, M. Zelefsky, R. Barakat, 2001 .

A review of the challenges faced in the conservative treatment of young women with endometrial carcinoma and risk of ovarian cancer.

R. Barakat, N. Kauff, J. Carter, 2009, Gynecologic oncology.

Recurrent cervical cancer isolated to the sigmoid colon: A case report☆

R. Barakat, Josephine S. Kim, J. Barlin, 2013, Gynecologic oncology case reports.

Sentinel lymph node mapping in patients with vulvar malignancies using indocyanine green and near-infrared imaging: Preliminary detection rate experience

D. Levine, R. Barakat, G. Gardner, 2015 .

Salvage weekly paclitaxel in recurrent ovarian cancer.

R. Barakat, C. Aghajanian, D. Spriggs, 1997, Seminars in oncology.

Sonohysterography compared with endometrial biopsy for evaluation of the endometrium in tamoxifen-treated women.

M. Gonen, R. Barakat, L. Hann, 2004, Journal of ultrasound in medicine : official journal of the American Institute of Ultrasound in Medicine.

Introduction of a computer-based surgical platform in the surgical care of patients with newly diagnosed uterine cancer: outcomes and impact on approach.

D. Levine, R. Barakat, D. Chi, 2012, Gynecologic oncology.

Enhancement of Ovarian Malignancy on Clinical Contrast Enhanced MRI Studies

H. Hricak, H. Pannu, R. Barakat, 2013, ISRN obstetrics and gynecology.

Endometrial sampling diagnosis of FIGO grade 1 endometrial adenocarcinoma with a background of complex atypical hyperplasia and final hysterectomy pathology.

R. Barakat, D. Chi, M. Leitao, 2010, American journal of obstetrics and gynecology.

Vulvovaginal melanoma: An institutional experience

R. Barakat, D. Chi, R. Carvajal, 2013 .

The accuracy of frozen-section diagnosis in metastatic breast and colorectal carcinoma to the adnexa.

R. Barakat, P. Saigo, D. Chi, 1999, Gynecologic oncology.

Lysophosphatidic acid acyltransferase‐β (LPAAT‐β) is highly expressed in advanced ovarian cancer and is associated with aggressive histology and poor survival

R. Barakat, A. Iasonos, C. Hedvat, 2006 .

Total laparoscopic radical hysterectomy with pelvic lymphadenectomy using the argon-beam coagulator: pilot data and comparison to laparotomy.

E. Venkatraman, R. Barakat, D. Chi, 2003, Gynecologic oncology.

Intraperitoneal chemotherapy in the management of ovarian cancer

R. Barakat, P. Saigo, B. Mychalczak, 1993 .

0126: Squamous Cell Carcinoma Arising in Mature Cystic Teratoma of the Ovary: a Case Series and Review of the Literature

R. Barakat, A. Iasonos, C. Aghajanian, 2006, International Journal of Gynecologic Cancer.

Lysophosphatidic acid acyltransferase-beta (LPAAT-beta) is highly expressed in advanced ovarian cancer and is associated with aggressive histology and poor survival.

R. Barakat, A. Iasonos, J. Dupont, 2006, Cancer.

Endometrial pathology at dilatation and curettage in breast cancer patients: comparison of tamoxifen users and nonusers.

R. Barakat, W. Hoskins, E. Venkatraman, 1996, The cancer journal from Scientific American.

Should Women Receiving Tamoxifen for Breast Cancer Be Screened for Endometrial Cancer?

R. Barakat, 2000, Cancer Investigation.

Tamoxifen and Endometrial Cancer.

R. Barakat, Barakat, 1996, Cancer control : journal of the Moffitt Cancer Center.

Advances in the Treatment of Gynecologic Malignancies

R. Barakat, N. Abu-Rustum, 2002 .

Sentinel lymph node biopsy in the management of early-stage cervical carcinoma.

Melissa P. Murray, R. Barakat, D. Chi, 2011, Gynecologic oncology.

A review of the challenges faced in the conservative treatment of young women with endometrial carcinoma and risk of ovarian cancer.

R. Barakat, N. Kauff, J. Carter, 2009, Gynecologic oncology.

A comparison of primary intraperitoneal chemotherapy to consolidation intraperitoneal chemotherapy in optimally resected advanced ovarian cancer.

R. Barakat, D. Chi, E. Tanner, 2014, Gynecologic oncology.

Laparoscopic findings during adnexal surgery in women with a history of nongynecologic malignancy.

R. Barakat, D. Chi, Y. Sonoda, 2006, Gynecologic oncology.

Risk factors for recurrence of ovarian borderline tumors.

R. Barakat, D. Chi, A. Iasonos, 2011, Gynecologic oncology.

The importance of applying a sentinel lymph node mapping algorithm in endometrial cancer staging: beyond removal of blue nodes.

R. Barakat, D. Chi, D. DeLair, 2012, Gynecologic oncology.

Low risk of complications associated with the fenestrated peritoneal catheter used for intraperitoneal chemotherapy in ovarian cancer.

D. Levine, R. Barakat, D. Chi, 2008, Gynecologic oncology.

Recurrence and survival after random assignment to laparoscopy versus laparotomy for comprehensive surgical staging of uterine cancer: Gynecologic Oncology Group LAP2 Study.

R. Barakat, J. Thigpen, R. Mannel, 2012, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Establishing a sentinel lymph node mapping algorithm for the treatment of early cervical cancer.

R. Barakat, D. Chi, Kay J. Park, 2011, Gynecologic oncology.

External validation of a nomogram predicting overall survival of patients diagnosed with endometrial cancer.

R. Barakat, A. Iasonos, N. Concin, 2012, Gynecologic oncology.

Introduction of a computer-based surgical platform in the surgical care of patients with newly diagnosed uterine cancer: outcomes and impact on approach.

D. Levine, R. Barakat, D. Chi, 2012, Gynecologic oncology.

A nomogram to predict postresection 5‐year overall survival for patients with uterine leiomyosarcoma

L. Jacks, R. Barakat, D. Chi, 2012, Cancer.

Tertiary cytoreduction in patients with recurrent epithelial ovarian, fallopian tube, or primary peritoneal cancer: an updated series.

R. Barakat, D. Chi, M. Leitao, 2010, Gynecologic oncology.

Multi-center prospective analysis of risk-reducing salpingo-oophorectomy to prevent BRCA-associated breast and ovarian cancer.

T. Rebbeck, L. Norton, K. Offit, 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

A prospective study of the feasibility and acceptability of a Web-based, electronic patient-reported outcome system in assessing patient recovery after major gynecologic cancer surgery.

E. Basch, R. Barakat, D. Chi, 2012, Gynecologic oncology.

Intraperitoneal administration of Taxol in the management of ovarian cancer.

R. Barakat, J. Lewis, E. Rowinsky, 1993, Journal of the National Cancer Institute. Monographs.